MouradAStraubeSArmijo-OlivoSGiandeckiR. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2019;181:450-458.
2.
ZhangMZhengBChenHChienC. Clinical effects of antidiabetic drugs on psoriasis: the perspective medicine. World J Diabetes. 2021;12(8):1141-1145.
3.
PatouliasDPopovicDSStoainAPJanezASahebkarARizzoM. Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials. J Diabetes Complications. 2023;37:108529.
4.
CostanzoGCuratoloSBusàBBelfioreAGulloD. Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient. Endocrinol Diabetes Metab Case Rep. 2021;2021:21-0007.
5.
MalavazosAEMeregalliCSorrentinoF, et alSemaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes. Endocrinol Diabetes Metab Case Rep. 2023;3:23-0017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
